share_log

MIRA Pharmaceuticals | 8-K: Current report

MIRA Pharmaceuticals | 8-K: Current report

MIRA Pharmaceuticals | 8-K:重大事件
美股SEC公告 ·  2024/09/12 20:34

牛牛AI助理已提取核心訊息

MIRA Pharmaceuticals held its 2024 Annual Meeting on September 12, with 63.72% of shareholders participating, representing 9,418,088 shares. Stockholders approved all major proposals, including the election of five directors: Erez Aminov, Michael Jerman, Matthew Del Giudice, M.D., Denil Nanji Shekhat, M.D., and Edward MacPherson.Shareholders overwhelmingly ratified Cherry Bekaert LLP as the company's independent registered public accounting firm for fiscal year 2024, with 9,408,950 votes in favor. Additionally, stockholders approved amendments to the 2022 Omnibus Incentive Plan to increase available shares, receiving 6,571,765 supporting votes. The fourth proposal regarding meeting adjournment was withdrawn as unnecessary due to the approval of other proposals.
MIRA Pharmaceuticals held its 2024 Annual Meeting on September 12, with 63.72% of shareholders participating, representing 9,418,088 shares. Stockholders approved all major proposals, including the election of five directors: Erez Aminov, Michael Jerman, Matthew Del Giudice, M.D., Denil Nanji Shekhat, M.D., and Edward MacPherson.Shareholders overwhelmingly ratified Cherry Bekaert LLP as the company's independent registered public accounting firm for fiscal year 2024, with 9,408,950 votes in favor. Additionally, stockholders approved amendments to the 2022 Omnibus Incentive Plan to increase available shares, receiving 6,571,765 supporting votes. The fourth proposal regarding meeting adjournment was withdrawn as unnecessary due to the approval of other proposals.
MIRA製藥公司於2023年9月12日召開了2024年年度會議,63.72%的股東參與,代表9,418,088股。股東一致通過了所有主要提案,包括選舉五名董事:Erez Aminov、Michael Jerman、Matthew Del Giudice萬.D.、Denil Nanji Shekhat萬.D.和Edward MacPherson。股東們以9,408,950票壓倒性批准了Cherry Bekaert LLP作爲公司2024財政年度的獨立註冊公共會計師。此外,股東們還批准了對2022年綜合激勵計劃的修訂,以增加可用股份,獲得6,571,765票支持。關於會議休會的第四項提案因其他提案的批准而被視爲不必要而撤回。
MIRA製藥公司於2023年9月12日召開了2024年年度會議,63.72%的股東參與,代表9,418,088股。股東一致通過了所有主要提案,包括選舉五名董事:Erez Aminov、Michael Jerman、Matthew Del Giudice萬.D.、Denil Nanji Shekhat萬.D.和Edward MacPherson。股東們以9,408,950票壓倒性批准了Cherry Bekaert LLP作爲公司2024財政年度的獨立註冊公共會計師。此外,股東們還批准了對2022年綜合激勵計劃的修訂,以增加可用股份,獲得6,571,765票支持。關於會議休會的第四項提案因其他提案的批准而被視爲不必要而撤回。

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
評論 評論 · 瀏覽 298

熱點推薦

聲明

本頁的譯文內容由軟件翻譯。富途將竭力但卻不能保證翻譯內容之準確和可靠,亦不會承擔因任何不準確或遺漏而引起的任何損失或損害。